A look at the clinical, economic, and societal impact of antimicrobial resistance in 2020

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Population genomics of Klebsiella pneumoniae

(2020) Kelly L. Wyres et al.   NATURE REVIEWS MICROBIOLOGY

Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing

(2020) Timothy M Rawson et al.   CLINICAL INFECTIOUS DISEASES

Alternatives to antibiotics in a One Health context and the role genomics can play in reducing antimicrobial use

(2020) J. Pollock et al.   CLINICAL MICROBIOLOGY AND INFECTION

Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

(2020) M. Bassetti et al.   CLINICAL MICROBIOLOGY AND INFECTION

COVID-19 and the potential long-term impact on antimicrobial resistance

(2020) Timothy M Rawson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

How covid-19 is accelerating the threat of antimicrobial resistance

(2020) Jeremy Hsu   BMJ-British Medical Journal

Antimicrobial use, drug-resistant infections and COVID-19

(2020) Timothy M. Rawson et al.   NATURE REVIEWS MICROBIOLOGY

UK launches subscription style model for antibiotics to encourage new development

(2020) Elisabeth Mahase   BMJ-British Medical Journal

Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage

(2019) Rene S. Hendriksen et al.   Nature Communications

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

(2019) Brian T. Tsuji et al.   PHARMACOTHERAPY

Defining and combating antibiotic resistance from One Health and Global Health perspectives

(2019) Sara Hernando-Amado et al.   Nature Microbiology

Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications

(2019) D.R. Giacobbe et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antibiotic development — economic, regulatory and societal challenges

(2019) Christine Årdal et al.   NATURE REVIEWS MICROBIOLOGY

The global preclinical antibacterial pipeline

(2019) Ursula Theuretzbacher et al.   NATURE REVIEWS MICROBIOLOGY

Ceftazidime/avibactam, Meropenem/vaborbactam or both? Clinical and formulary considerations

(2018) Jason M Pogue et al.   CLINICAL INFECTIOUS DISEASES

Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria

(2018) Daniele Roberto Giacobbe et al.   Expert Review of Clinical Pharmacology

Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy

(2017) Daniele Roberto Giacobbe et al.   INFECTION

Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach

(2017) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

DNA sequencing at 40: past, present and future

(2017) Jay Shendure et al.   NATURE

Global infection prevention and control priorities 2018–22: a call for action

(2017) Benedetta Allegranzi et al.   Lancet Global Health

Why is antibiotic resistance a deadly emerging disease?

(2016) P. Courvalin   CLINICAL MICROBIOLOGY AND INFECTION

Multidrug-Resistant Bacteria in the Community

(2016) David van Duin et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Antimicrobial Resistance

(2016) Hilary D. Marston et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antibacterial drug discovery in the resistance era

(2016) Eric D. Brown et al.   NATURE

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins

(2015) M. Berrazeg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Economic burden of antibiotic resistance: how much do we really know?

(2014) S. Gandra et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clinical, economic and societal impact of antibiotic resistance

(2014) Steven L Barriere   EXPERT OPINION ON PHARMACOTHERAPY

The Perpetual Challenge of Antimicrobial Resistance

(2014) Anthony S. Fauci et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Origins and Evolution of Antibiotic Resistance

(2010) J. Davies et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS